Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-18 Sale | 2026-02-19 7:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 13,426 | $3.08 | $41,352 | 1,195,349 (Direct) | View |
| 2025-12-29 Sale | 2025-12-30 7:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 21,383 | $4.18 | $89,381 | 761,550 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-17 Tax Withholding | 2026-02-19 7:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $3.49 | 1,195,349 (Direct) | View |
| 2026-02-06 Tax Withholding | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,400 | $3.98 | 1,220,683 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-10 6:18 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 470,533 | $0 | 1,220,683 (Direct) | View |
| 2025-12-15 Tax Withholding | 2025-12-17 6:34 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.33 | 782,933 (Direct) | View |
| 2025-11-25 Tax Withholding | 2025-11-26 5:14 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 2,271 | $4.03 | 789,990 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 7:37 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $4.14 | 792,261 (Direct) | View |
| 2025-09-15 Tax Withholding | 2025-09-17 4:45 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.83 | 804,169 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-19 6:22 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $5.64 | 811,226 (Direct) | View |
| 2025-06-16 Tax Withholding | 2025-06-18 4:32 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $4.92 | 2,097,596 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-05-19 4:44 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 11,908 | $4.25 | 2,104,653 (Direct) | View |
| 2025-04-01 Tax Withholding | 2025-04-03 4:38 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 26,571 | $5.095 | 2,116,561 (Direct) | View |
| 2025-03-17 Tax Withholding | 2025-03-19 4:27 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $6.84 | 2,143,132 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 4:42 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 10,879 | $10.64 | 2,150,189 (Direct) | View |
| 2025-02-03 Tax Withholding | 2025-02-05 4:50 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 6,544 | $7.25 | 2,161,068 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 4:50 pm | N/A 2035-02-03 | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 118,977 | $0 | 2,161,068 (Direct) | View |
| 2024-12-19 Option Award | 2024-12-20 4:16 pm | N/A 2034-12-18 | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 1,111,029 | $0 | 2,048,635 (Direct) | View |
| 2024-12-17 Tax Withholding | 2024-12-18 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 7,057 | $6.95 | 473,867 (Direct) | View |
| 2024-12-16 Tax Withholding | 2024-12-18 6:49 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 15,668 | $6.04 | 473,867 (Direct) | View |
Ownership | 2024-12-02 7:02 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer | 0 | $0 | 960,331 (Direct) | View |